Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (13)

« Back to Publications

The Effect of Acute Knee Injuries and Related Knee Surgery on Serum Levels of Pro- and Anti-inflammatory Lipid Mediators and Their Associations With Knee Symptoms.

Turnbull J. et al, (2024), Am J Sports Med, 52, 987 - 997

Development of methodology to support molecular endotype discovery from synovial fluid of individuals with knee osteoarthritis: The STEpUP OA consortium.

Deng Y. et al, (2024), PLoS One, 19

Clinical and molecular associations with outcomes at two years after acute knee injury: a longitudinal study in the Knee Injury Cohort at the Kennedy (KICK)

Garriga C. et al, (2021), Lancet Rheumatology

Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

Barrett JR. et al, (2021), Nature medicine

Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

Barrett JR. et al, (2021), Nature medicine

The role and uses of antibodies in COVID-19 infections: a living review.

Scourfield DO. et al, (2021), Oxf Open Immunol, 2

Overview of approved and upcoming vaccines for SARS-CoV-2: a living review.

Alderson J. et al, (2021), Oxf Open Immunol, 2

Factors influencing the re-emergence of plague in Madagascar.

Alderson J. et al, (2020), Emerg Top Life Sci, 4, 411 - 421

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a Phase 1/2 clinical trial.

LAMBE T. et al, (2020), Nature Medicine

Multisystem inflammatory syndrome in children: getting to the heart of the matter.

Cavounidis A. et al, (2020), Nat Rev Immunol, 20

SARS-CoV-2: too infectious to handle?

Coveney C. and Alderson J., (2020), Nat Rev Immunol, 20

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Barrett JR. et al, (2020), Nat Med

Active Immunisation Targeting Nerve Growth Factor Attenuates Chronic Pain Behaviour in Murine Osteoarthritis

VINCENT ANTONIA. et al, (2019), Annals of the Rheumatic Diseases